Sinopharm Group Co. Ltd. (FRA:X2S)

Sinopharm Group had revenue of 144.38B CNY in the quarter ending June 30, 2025, a decrease of -2.09%. This brings the company's revenue in the last twelve months to 575.82B, down -2.46% year-over-year. In the year 2024, Sinopharm Group had annual revenue of 584.51B, down -2.02%.

• Revenue (ttm): 575.82B CNY
• Revenue Growth: -2.46%
• P/S Ratio: 0.10
• Revenue / Employee: 5.32M CNY
• Employees: 108,217
• Market Cap: 6.77B EUR

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	584.51B	-12.06B	-2.02%
Dec 31, 2023	596.57B	44.42B	8.05%
Dec 31, 2022	552.15B	31.10B	5.97%
Dec 31, 2021	521.05B	64.64B	14.16%
Dec 31, 2020	456.41B	31.14B	7.32%